Loading…

Tobacco Regulatory Research: Agent

Select Protocol ID

Tobacco Laboratory, Nicotine (Total and Unprotonated), Version 03
#730301

National Adult Tobacco Survey (NATS), 2009 and the Population Assessment of Tobacco and Health (PATH) Survey, 2023
#730402

Massachusetts Benchmark Study (MBS), 1999
#730501

Federal Register Notice, Laboratory measurement, 74 Fed. Reg. 4, Jan. 7, 2009
#730502

National Survey on Drug Use and Health (NSDUH), 2021, Population Assessment of Tobacco and Health (PATH) Study Wave 7
#730708

Current Population Survey (CPS), Tobacco Supplement, 2018-2019, Population Assessment of Tobacco and Health (PATH) Study Wave 7
#730707

Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 - December 2022)
#730704

Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 - December 2022) & International Tobacco Control 4-Country Survey, 2015
#730902
Release Date:

June 24, 2015

Scope of Collection
Element Considered Final Measures in Toolkit
Brand and variety Tobacco Brand and Variety - Cigarettes
Tobacco Brand and Variety - Cigars
Tobacco Brand and Variety - Smokeless Tobacco
Consumption measurements Quantity, frequency, duration used
Abuse liability Constituents that enhance abuse liability, for example
Product adulteration Tobacco Product Adulteration - Vent or Filter Blocking
Product appeal
Product constituents Nicotine Content
Product emissions
Product characterization
Product physical assessments / product design features Physical Properties of Tobacco Products - Cigarettes and Filtered Cigars
Physical Properties of Tobacco Products - Smokeless Tobacco
Topography measures
Toxicology
Warning label awareness and exposure Passive Exposures to Tobacco Products
Working Group Roster:

WG Members:

Richard J. O'Connor, PhD, Co-Chair
Roswell Park Cancer Institute
Department of Health Behavior
Buffalo, NY
Clifford H. Watson, PhD, Co-Chair
Centers for Disease Control and Prevention
Atlanta, GA
Marielle C. Brinkman
Battelle Memorial Institute
Columbus, OH
Barry G. Green, PhD
Yale University
Biological and Biomedical Sciences
New Haven, CT
David Hammond, PhD, MSc
University of Waterloo
School of Public Health and Health Systems
Waterloo, Ontario, Canada,
James F. Pankow, PhD
Portland State University
Portland, OR
Irina Stepanov, PhD
University of Minnesota, Twin Cities
Masonic Cancer Center Division of Environmental Health Sciences
Minneapolis, MN

Tobacco Regulatory Research Panel Liaison, WG Manager and WG Supervisor:

Neal L. Benowitz, MD, Tobacco Regulatory Research Panel Liaison
University of California, San Francisco
San Francisco, CA
Dana M. van Bemmel, PhD, MPH, Tobacco Regulatory Research Panel Liaison
Food and Drug Administration (FDA)
Center for Tobacco Products
Silver Spring, MD
Destiney Nettles, MPM, WG Supervisor
RTI International
Research Triangle Park, NC
Rebecca Geisler, WG Manager
RTI International
Research Triangle Park, NC

FDA Center for Tobacco Products Liaison:

Tricia Johnson, MA
Food and Drug Administration (FDA)
Center for Tobacco Products
Silver Spring, MD

National Institute on Drug Abuse Liaison:

Kevin M. Walton, PhD
National Institute on Drug Abuse (NIDA)
Rockville, MD
Content Expert Panel #1 - Tobacco Regulatory Research:

CEP Members:

Meghan Morean, PhD, Co-Lead
Yale University
New Haven, CT
Cassandra Stanton, PhD, Co-Lead
Westat
Rockville, MD
Neal L. Benowitz, MD
University of California, San Francisco
San Francisco, CA
Kurt Ribisl, PhD, MA
University of North Carolina at Chapel Hill
Chapel Hill, NC
Michelle Bover-Manderski, PhD
Rutgers University
New Brunswick, NJ
Brittney Keller-Hamilton, PhD
The Ohio State University
Columbus, OH
Jenny Ozga, PhD
Westat
Rockville, MD
Shyanika Rosa, PhD
University of Kentucky
Lexington, KY

SC Liaison and CEP Manager:

Tabitha P. Hendershot, BA, SC Liaison
RTI International
Washington, DC
Lisa Cox, MS, CEP Manager
RTI International
Atlanta, GA

Supplemental Information includes protocols that the Working Group or Expert Review Panel considered useful and highly relevant to the domain but do not meet the criteria for inclusion in the Toolkit.

Tobacco Regulatory Research: Agent Supplemental Information includes:
Additional Information:

There is no additional information for this collection.